Page 95 - Markets

Motilal Oswal sees 43% upside for Suzlon; strong outlook lifts stock 2%

Motilal Oswal has a 'Buy' rating on Suzlon Energy with a target price of ₹74, an upside potential of 43 per cent from the previous close

Auto ancillaries to outpace OEMs, says Elara; check key drivers, top picks

Elara identified four factors critical for auto ancillary companies to outperform OEMs: product expansion, segment expansion, geographic expansion and inorganic initiatives

SPML Infra share price zooms 10% on winning ₹207-crore JV project

SPML Infra shares surged 10 per cent after it bagged a ₹207 crore joint venture project from the Public Health Engineering Department of Rajasthan

Wakefit Innovations IPO opens today: Check GMP, price band, dates, review

Ahead of its IPO, Wakefit Innovations raised ₹580 crore from 33 institutional investors via an anchor book on December 5

PL Capital retains 'Accumulate' on Shree Cement, trims target; here's why

With industry peers increasingly adopting similar strategies, PL Capital highlighted that the company may need to recalibrate its approach, leveraging core strengths to accelerate volume growth

Nuvama lifts Sona BLW's target price on strong railway, EV motor growth

Nuvama expects Sona BLW's revenue and Ebitda to expand at a CAGR of 20 per cent and 17 per cent, respectively, over FY25-28E

Meesho IPO subscribed 79x; check allotment status, GMP, listing date

Meesho IPO allotment: Applicants can verify their status through the NSE and BSE websites or by visiting the IPO registrar, Kfin Technologies

Indus Towers, Policybazaar among top analyst bets; check target, stop-loss

Indus Towers has consistently traded above all its significant EMAs, reflecting a positive market sentiment, and Policybazaar has also demonstrated a consistent performance

Stocks to Watch today: Adani Enterprises, ICICI Bank, Biocon, Ola Electric

Stocks to Watch today, December 8, 2025: Bajaj Finserv, ONGC, AU Small Finance Bank, P N Gadgil Jewellers, Cochin Shipyard, Delhivery, and TVS Motor Company are among the top stock to remain in focus

IndiGo flight cancellation: Use fall to buy for the long term, say analysts

IndiGo share price has corrected sharply amid mass flight cancellations. Analysts say the dip may offer a long-term entry opportunity despite near-term volatility

Near-term margin pressure for city gas distribution companies' stocks

Since administered pricing mechanism (APM) and new well gas (NWG) prices are tied to global prices, which are tied to crude, this may be a positive

Kaynes Technology crashes 13%, hits eight-month low; brokerages cautious

In the past one month, Kaynes Tech stock has tanked 31 per cent as compared to 2.3 per cent rise in the BSE Sensex

Stock Market close: Sensex jumps 447 pts, Nifty at 26,186 as investors cheer RBI rate cut

Sensex Today | Stock Market close, Dec 5, 2025: In the broader markets, the Nifty MidCap index gained 0.49 per cent, and the Nifty SmallCap index dropped 0.57 per cent

Last day to bid for Vidya Wires IPO: Check subscription status, GMP

Investors placed bids for 969 million shares in the Vidya Wires IPO, compared with the 43.33 million shares available, translating to a subscription level of 22.35 times

IPO Calendar: D-Street braces for 9 new issues; Meesho, Aequs listings

IPO Calendar: Nephrocare, Park Medi World, Wakefit Innovations, and Corona Remedies, are set to open for subscription, aiming to raise a combined ₹3,735 crore

Gold trades in a tight band with constructive bias; dip buying favoured

The yellow metal, at the time of writing this article, was trading at $4,213, up nearly 0.2 per cent for the day, even as the US yields firmed up

Last day! Aequs IPO closes today; subscription rises 28x, GMP at 37%

Aequs IPO subscription status: Among the investor categories, retail investors led the demand, with the portion reserved for them subscribed by 56.62 times

Corona Remedies IPO opens Dec 8: Bid or skip? Here's what experts suggest

Corona Remedies IPO Date: The unlisted shares of Corona Remedies were trading at ₹1,427, commanding a grey market premium of ₹365 or 34.4 per cent on Friday

Park Medi World IPO opens Dec 10; sets price band at ₹154-162: Key details

Park Medi World is eyeing ₹770 crore through the fresh issue for 47.5 million equity shares, and shareholders will be selling 9.3 million equity shares through an OFS for ₹150 crore

Motilal Oswal retains 'Buy' on JSW Infra as FY30 growth roadmap strengthens

With a balanced east-west coast presence and expanding inland logistics capabilities, JSWINFRA, analysts believe, is well-placed to benefit from India's push for multimodal integration